---
figid: PMC7903655__13578_2021_554_Fig2_HTML
figlink: pmc/articles/PMC7903655/figure/Fig2/
number: F2
caption: Mechanism by which MSCs regulate macrophage polarization in the context of
  SCI. MSCs can promote the polarization of macrophages at the site of SCI by secreting
  soluble proteins including IL-4, IL-13, PACAP, CCL2, CCL5, and ED-Siglec-9. IL-4
  can activate the JNK, JAK/STAT6, and PI3K signal pathways through IL-4R, and ultimately
  promote the expression of M2 related genes. In turn, IL-13 activates IL-10R, thereby
  participating in the process by acting on STAT6. In addition, CCL5 can induce high
  levels of IL-4 by acting on CCL5R, thereby promoting M2 polarization of macrophages.
  CCL2 can induce the expression of MCPIP through CCR2, thereby activating C/EBPβ,
  PPARγ, and inhibiting NF-κB to exert anti-inflammatory effects. ED-Siglec-9 also
  works synergistically with CCR2. Regarding PACAP, its mechanism of action is not
  yet clear. Furthermore, MSCs-exo can also play a similar role, by carrying MiR-216a-5p
  and lncRNAs Gm37494, which will inhibit TLR4/NF-κB and activate PI3K/AKT signaling
  pathway, and downregulate the expression of MiR-130b-3p and upregulate the expression
  of PPARγ, respectively, hence, inhibiting M1 and enhancing M2 marker expression.
  Lastly, MSCs can improve the inflammatory environment of the SCI site and relieve
  its manifestations. AKT, protein kinase B; CCL, chemokine (C-C motif) ligand; CCR,
  chemokine (C-C motif) receptor; C/EBPβ, CCAAT/enhancer-binding protein beta; ED-Siglec-9,
  ectodomain of sialic acid-binding Ig-like lectin-9; IL, interleukin; JAK, Janus
  kinase; JNK, c-Jun N-terminal kinase; lncRNAs, long non-coding RNAs; MCPIP, monocyte
  chemoattractant protein-1-induced protein.; MSCs, mesenchymal stem cells; NF-κB,
  nuclear factor kappa-B; PACAP, pituitary adenylate cyclase-activating polypeptide;
  PI3K, phosphoinositide 3-kinase; PPARβ, peroxisome-proliferator-activated receptor
  β; SCI, spinal cord injury; TLR, Toll-like receptor
pmcid: PMC7903655
papertitle: Mechanism of mesenchymal stem cells in spinal cord injury repair through
  macrophage polarization.
reftext: Nan An, et al. Cell Biosci. 2021;11:41.
pmc_ranked_result_index: '112732'
pathway_score: 0.9607913
filename: 13578_2021_554_Fig2_HTML.jpg
figtitle: Mechanism by which MSCs regulate macrophage polarization in the context
  of SCI
year: '2021'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7903655__13578_2021_554_Fig2_HTML.html
  '@type': Dataset
  description: Mechanism by which MSCs regulate macrophage polarization in the context
    of SCI. MSCs can promote the polarization of macrophages at the site of SCI by
    secreting soluble proteins including IL-4, IL-13, PACAP, CCL2, CCL5, and ED-Siglec-9.
    IL-4 can activate the JNK, JAK/STAT6, and PI3K signal pathways through IL-4R,
    and ultimately promote the expression of M2 related genes. In turn, IL-13 activates
    IL-10R, thereby participating in the process by acting on STAT6. In addition,
    CCL5 can induce high levels of IL-4 by acting on CCL5R, thereby promoting M2 polarization
    of macrophages. CCL2 can induce the expression of MCPIP through CCR2, thereby
    activating C/EBPβ, PPARγ, and inhibiting NF-κB to exert anti-inflammatory effects.
    ED-Siglec-9 also works synergistically with CCR2. Regarding PACAP, its mechanism
    of action is not yet clear. Furthermore, MSCs-exo can also play a similar role,
    by carrying MiR-216a-5p and lncRNAs Gm37494, which will inhibit TLR4/NF-κB and
    activate PI3K/AKT signaling pathway, and downregulate the expression of MiR-130b-3p
    and upregulate the expression of PPARγ, respectively, hence, inhibiting M1 and
    enhancing M2 marker expression. Lastly, MSCs can improve the inflammatory environment
    of the SCI site and relieve its manifestations. AKT, protein kinase B; CCL, chemokine
    (C-C motif) ligand; CCR, chemokine (C-C motif) receptor; C/EBPβ, CCAAT/enhancer-binding
    protein beta; ED-Siglec-9, ectodomain of sialic acid-binding Ig-like lectin-9;
    IL, interleukin; JAK, Janus kinase; JNK, c-Jun N-terminal kinase; lncRNAs, long
    non-coding RNAs; MCPIP, monocyte chemoattractant protein-1-induced protein.; MSCs,
    mesenchymal stem cells; NF-κB, nuclear factor kappa-B; PACAP, pituitary adenylate
    cyclase-activating polypeptide; PI3K, phosphoinositide 3-kinase; PPARβ, peroxisome-proliferator-activated
    receptor β; SCI, spinal cord injury; TLR, Toll-like receptor
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ARG1
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - MAPK8
  - MAPK9
  - MAPK10
  - IL4
  - IL13
  - IL4R
  - AKT2
  - AKT3
  - AKT1
  - CCL5
  - CCL2
  - STAT6
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - IL13RA2
  - CCR2
  - CCR5
  - Arg
  - Gm37494
genes:
- word: Arg-1
  symbol: ARG1
  source: hgnc_symbol
  hgnc_symbol: ARG1
  entrez: '383'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: IL-4
  symbol: IL-4
  source: hgnc_alias_symbol
  hgnc_symbol: IL4
  entrez: '3565'
- word: IL-13
  symbol: IL-13
  source: hgnc_alias_symbol
  hgnc_symbol: IL13
  entrez: '3596'
- word: IL-4
  symbol: IL-4
  source: hgnc_alias_symbol
  hgnc_symbol: IL4
  entrez: '3565'
- word: IL-4R
  symbol: IL4R
  source: hgnc_symbol
  hgnc_symbol: IL4R
  entrez: '3566'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: CCL5
  symbol: CCL5
  source: hgnc_symbol
  hgnc_symbol: CCL5
  entrez: '6352'
- word: CCL2
  symbol: CCL2
  source: hgnc_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: STAT6-
  symbol: STAT6
  source: hgnc_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: IL-13
  symbol: IL-13
  source: hgnc_alias_symbol
  hgnc_symbol: IL13
  entrez: '3596'
- word: IL-13R
  symbol: IL-13R
  source: hgnc_alias_symbol
  hgnc_symbol: IL13RA2
  entrez: '3598'
- word: CCL2
  symbol: CCL2
  source: hgnc_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: CCR2
  symbol: CCR2
  source: hgnc_symbol
  hgnc_symbol: CCR2
  entrez: '729230'
- word: CCR5
  symbol: CCR5
  source: hgnc_symbol
  hgnc_symbol: CCR5
  entrez: '1234'
- word: IL-4
  symbol: IL-4
  source: hgnc_alias_symbol
  hgnc_symbol: IL4
  entrez: '3565'
chemicals:
- word: Arg
  source: MESH
  identifier: C076685
- word: Gm37494
  source: MESH
  identifier: C044261
diseases: []
figid_alias: PMC7903655__F2
redirect_from: /figures/PMC7903655__F2
figtype: Figure
---
